Shares of Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) made a solid gain to kick off the week after the company gave an update on one of its clinical programs. Specifically, the firm provided more ...
SOUTH SAN FRANCISCO, Calif., Jan. 9, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today ...
SOUTH SAN FRANCISCO, Calif., Dec. 7, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today ...
A look at the shareholders of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 57% ownership.
SOUTH SAN FRANCISCO, Calif., June 3, 2020 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that data related to R835, the company's investigational IRAK1/4 inhibitor, will be ...
One of the prettiest stars in the winter evening sky has to be Rigel, the bright blue-white “foot” of the constellation Orion the Hunter. Actually, it is hard to say which is the prettiest star. After ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback